M&A Deal Summary |
|
---|---|
Date | 2010-12-20 |
Target | Aeon Bioscience |
Sector | Life Science |
Buyer(s) | Arresto Biosciences |
Sellers(s) | Greer Capital Advisors |
Deal Type | Add-on Acquisition |
Deal Value | 255M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2007 |
Sector | Life Science |
Arresto Biosciences is a biotechnology company that develops medicines to treat fibrotic diseases and cancer by targeting enzymes involved in the synthesis of the extracellular matrix. In addition to AB0024, the company has preclinical candidates targeting proteins associated with various inflammatory diseases. The company is headquartered in Palo Alto, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Alabama) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2010) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
Category | Private Equity Firm |
---|---|
Founded | 2002 |
Size | Small |
Type | Sector Focused |
Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.
DEAL STATS | # |
---|---|
Overall | 5 of 13 |
Sector (Life Science) | 4 of 10 |
Type (Add-on Acquisition) | 4 of 10 |
State (Alabama) | 2 of 7 |
Country (United States) | 5 of 13 |
Year (2010) | 1 of 2 |
Size (of disclosed) | 2 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-10-08 |
BioDtech
Birmingham, Alabama, United States BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-12-23 |
Atherotech
Birmingham, Alabama, United States Atherotech is a clinical reference laboratory specializing in diagnostic testing for cardio-metabolic disease. The Company’s proprietary “VAP” test allows physicians to identify at-risk patients through a variety of cholesterol and lipid bio-markers with much greater accuracy and at significantly lower cost to the health care system than competitive testing products. The company’s state-of-the-art central laboratory processes millions of tests annually. |
Sell | - |